Summary

The global Primary Care Point-of-Care (POC) Diagnostics market is set to experience substantial growth, expanding at a CAGR of 6.48% through 2032. The market is projected to reach $18.41 billion in 2025 and $28.56 billion in 2032, driven by advancements in diagnostic technologies, the rising prevalence of chronic diseases, and increasing demand for rapid diagnostic solutions in primary healthcare settings.

Market Insights

Primary Care POC diagnostics are medical tests conducted near the patient, facilitating rapid and accurate results. These tests enable medical professionals to make immediate decisions regarding patient care, leading to timely interventions and personalized treatment plans. The market encompasses a variety of diagnostic applications, including glucose testing, infectious diseases, cardiac markers, and hematology, among others. The sector is gaining momentum due to technological advancements that enhance efficiency and accuracy.

Market Growth Drivers

• Rising Prevalence of Chronic Diseases: The increasing incidence of chronic illnesses, such as cardiovascular diseases and diabetes, is a key factor driving the demand for POC diagnostics in primary care settings.

• Growing Need for Rapid and Accurate Testing: The demand for swift diagnostic solutions in primary healthcare facilities is rising as healthcare professionals seek to enhance patient outcomes through early disease detection and real-time monitoring.

• Technological Advancements: Innovations in connectivity, miniaturization, and digital integration are improving the functionality and accessibility of POC diagnostic tools, making them more reliable and efficient.

• Expansion of Healthcare Infrastructure: The increasing investment in healthcare infrastructure, especially in emerging economies, is contributing to market expansion.

• Shift Towards Preventive Healthcare: The focus on early disease detection and preventive healthcare solutions is further fueling market growth.

Business Opportunities

• Technological Advancements: Developments in AI-powered diagnostics, cloud-based data management, and miniaturization of devices are creating lucrative opportunities for industry players.

• Integration with Digital Health Ecosystems: The integration of POC devices with electronic health records (EHRs) and telemedicine platforms is expected to revolutionize the market.

• Expansion in Emerging Markets: Developing economies in South Asia and the Pacific present immense opportunities for market expansion due to increasing healthcare awareness and infrastructure growth.

• Strategic Collaborations: Companies are increasingly engaging in partnerships and acquisitions to expand their product portfolios and strengthen their market presence.

Regional Analysis

• North America: Expected to maintain the largest market share due to early adoption of advanced diagnostic technologies, strong healthcare infrastructure, and favorable reimbursement policies.

• Europe: Driven by increasing healthcare spending and emphasis on preventive diagnostics.

• South Asia & Pacific: Anticipated to witness the fastest growth due to rising healthcare awareness, an increasing burden of chronic diseases, and improving healthcare infrastructure.

• Latin America & Middle East & Africa: Emerging as promising regions due to growing investments in healthcare modernization.

Key Players in the Market

Leading companies in the global Primary Care POC Diagnostics market include:

• Roche Diagnostics

• BD Biosciences

• Danaher Corporation

• Abbott Laboratories

• Instrumentation Laboratory

• bioMérieux

• Siemens Healthcare

• Quidel Corporation

These companies are actively investing in research and development, strategic partnerships, and regulatory compliance to enhance their market position.

Strategic Initiatives & Competitive Intelligence

• Innovative R&D Investments: Companies are focusing on enhancing diagnostic accuracy, speed, and ease of use.

• Regulatory Compliance & Certifications: Adhering to global regulatory standards is crucial for market success.

• Mergers & Acquisitions: Strategic acquisitions are helping companies expand their product offerings and global presence.

• Digital Transformation: The adoption of cloud-based solutions and AI-powered diagnostics is shaping the future of the market.

Recent Developments

• Baxter International Inc. and Digital Diagnostics Partnership: In March 2022, these companies announced a collaboration to enhance the point-of-care detection of diabetic retinopathy using the Welch Allyn RetinaVue 700 Imager and IDx-DR autonomous AI software.

Market Segmentation

By Product:

• Glucose Testing

• Hb1Ac Testing

• Autoimmune Disease

• Coagulation

• Fertility

• Infectious Diseases

• Cardiac Markers

• Thyroid Stimulating Hormone

• Hematology

• Primary Care Systems

• Decentralized Clinical Chemistry

• Feces

• Lipid Testing

• Cancer Marker

• Blood Gas/Electrolytes

• Ambulatory Chemistry

• Drug Abuse Testing

• Urinalysis

By End User:

• Pharmacy & Retail Clinics

• Physician Offices

• Urgent Care Clinics

• Non-Practice Clinics

By Region:

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Primary Care POC Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Primary Care POC Diagnostics Market Outlook, 2019 - 2032
3.1. Global Primary Care POC Diagnostics Market Outlook, by Product Type, Value (US$ Bn) , 2019 - 2032
3.1.1. Key Highlights
3.1.1.1. Hb1Ac Testing
3.1.1.2. Glucose Testing
3.1.1.3. Autoimmune Disease
3.1.1.4. Coagulation
3.1.1.5. Fertility
3.1.1.6. Infectious Diseases
3.1.1.7. Cardiac Markers
3.1.1.8. Thyroid Stimulating Hormone
3.1.1.9. Hematology
3.1.1.10. Primary Care Systems
3.1.1.11. Decentralized Clinical Chemistry
3.1.1.12. Feces
3.1.1.13. Lipid Testing
3.1.1.14. Cancer Marker
3.1.1.15. Blood Gas/Electrolytes
3.1.1.16. Ambulatory Chemistry
3.1.1.17. Drug Abuse Testing
3.1.1.18. Urinalysis
3.2. Global Primary Care POC Diagnostics Market Outlook, by End User, Value (US$ Bn) , 2019 - 2032
3.2.1. Key Highlights
3.2.1.1. Pharmacy & Retail Clinics
3.2.1.2. Physician Office
3.2.1.3. Urgent Care Clinics
3.2.1.4. Non-practice Clinics
3.3. Global Primary Care POC Diagnostics Market Outlook, by Region, Value (US$ Bn) , 2019 - 2032
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Primary Care POC Diagnostics Market Outlook, 2019 - 2032
4.1. North America Primary Care POC Diagnostics Market Outlook, by Product Type, Value (US$ Bn) , 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Hb1Ac Testing
4.1.1.2. Glucose Testing
4.1.1.3. Autoimmune Disease
4.1.1.4. Coagulation
4.1.1.5. Fertility
4.1.1.6. Infectious Diseases
4.1.1.7. Cardiac Markers
4.1.1.8. Thyroid Stimulating Hormone
4.1.1.9. Hematology
4.1.1.10. Primary Care Systems
4.1.1.11. Decentralized Clinical Chemistry
4.1.1.12. Feces
4.1.1.13. Lipid Testing
4.1.1.14. Cancer Marker
4.1.1.15. Blood Gas/Electrolytes
4.1.1.16. Ambulatory Chemistry
4.1.1.17. Drug Abuse Testing
4.1.1.18. Urinalysis
4.2. North America Primary Care POC Diagnostics Market Outlook, by End User, Value (US$ Bn) , 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Pharmacy & Retail Clinics
4.2.1.2. Physician Office
4.2.1.3. Urgent Care Clinics
4.2.1.4. Non-practice Clinics
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Primary Care POC Diagnostics Market Outlook, by Country, Value (US$ Bn) , 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. U.S. Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
4.3.1.2. U.S. Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
4.3.1.3. Canada Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
4.3.1.4. Canada Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Primary Care POC Diagnostics Market Outlook, 2019 - 2032
5.1. Europe Primary Care POC Diagnostics Market Outlook, by Product Type, Value (US$ Bn) , 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Hb1Ac Testing
5.1.1.2. Glucose Testing
5.1.1.3. Autoimmune Disease
5.1.1.4. Coagulation
5.1.1.5. Fertility
5.1.1.6. Infectious Diseases
5.1.1.7. Cardiac Markers
5.1.1.8. Thyroid Stimulating Hormone
5.1.1.9. Hematology
5.1.1.10. Primary Care Systems
5.1.1.11. Decentralized Clinical Chemistry
5.1.1.12. Feces
5.1.1.13. Lipid Testing
5.1.1.14. Cancer Marker
5.1.1.15. Blood Gas/Electrolytes
5.1.1.16. Ambulatory Chemistry
5.1.1.17. Drug Abuse Testing
5.1.1.18. Urinalysis
5.2. Europe Primary Care POC Diagnostics Market Outlook, by End User, Value (US$ Bn) , 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Pharmacy & Retail Clinics
5.2.1.2. Physician Office
5.2.1.3. Urgent Care Clinics
5.2.1.4. Non-practice Clinics
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Primary Care POC Diagnostics Market Outlook, by Country, Value (US$ Bn) , 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Germany Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
5.3.1.2. Germany Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
5.3.1.3. U.K. Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
5.3.1.4. U.K. Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
5.3.1.5. France Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
5.3.1.6. France Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
5.3.1.7. Italy Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
5.3.1.8. Italy Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
5.3.1.9. Spain Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
5.3.1.10. Spain Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
5.3.1.11. Russia Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
5.3.1.12. Russia Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
5.3.1.13. Rest of Europe Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
5.3.1.14. Rest of Europe Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Primary Care POC Diagnostics Market Outlook, 2019 - 2032
6.1. Asia Pacific Primary Care POC Diagnostics Market Outlook, by Product Type, Value (US$ Bn) , 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Hb1Ac Testing
6.1.1.2. Glucose Testing
6.1.1.3. Autoimmune Disease
6.1.1.4. Coagulation
6.1.1.5. Fertility
6.1.1.6. Infectious Diseases
6.1.1.7. Cardiac Markers
6.1.1.8. Thyroid Stimulating Hormone
6.1.1.9. Hematology
6.1.1.10. Primary Care Systems
6.1.1.11. Decentralized Clinical Chemistry
6.1.1.12. Feces
6.1.1.13. Lipid Testing
6.1.1.14. Cancer Marker
6.1.1.15. Blood Gas/Electrolytes
6.1.1.16. Ambulatory Chemistry
6.1.1.17. Drug Abuse Testing
6.1.1.18. Urinalysis
6.2. Asia Pacific Primary Care POC Diagnostics Market Outlook, by End User, Value (US$ Bn) , 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Pharmacy & Retail Clinics
6.2.1.2. Physician Office
6.2.1.3. Urgent Care Clinics
6.2.1.4. Non-practice Clinics
6.2.2. BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Primary Care POC Diagnostics Market Outlook, by Country, Value (US$ Bn) , 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. China Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
6.3.1.2. China Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
6.3.1.3. Japan Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
6.3.1.4. Japan Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
6.3.1.5. South Korea Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
6.3.1.6. South Korea Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
6.3.1.7. India Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
6.3.1.8. India Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
6.3.1.9. Southeast Asia Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
6.3.1.10. Southeast Asia Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
6.3.1.11. Rest of Asia Pacific Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
6.3.1.12. Rest of Asia Pacific Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Primary Care POC Diagnostics Market Outlook, 2019 - 2032
7.1. Latin America Primary Care POC Diagnostics Market Outlook, by Product Type, Value (US$ Bn) , 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Hb1Ac Testing
7.1.1.2. Glucose Testing
7.1.1.3. Autoimmune Disease
7.1.1.4. Coagulation
7.1.1.5. Fertility
7.1.1.6. Infectious Diseases
7.1.1.7. Cardiac Markers
7.1.1.8. Thyroid Stimulating Hormone
7.1.1.9. Hematology
7.1.1.10. Primary Care Systems
7.1.1.11. Decentralized Clinical Chemistry
7.1.1.12. Feces
7.1.1.13. Lipid Testing
7.1.1.14. Cancer Marker
7.1.1.15. Blood Gas/Electrolytes
7.1.1.16. Ambulatory Chemistry
7.1.1.17. Drug Abuse Testing
7.1.1.18. Urinalysis
7.2. Latin America Primary Care POC Diagnostics Market Outlook, by End User, Value (US$ Bn) , 2019 - 2032
7.2.1.1. Pharmacy & Retail Clinics
7.2.1.2. Physician Office
7.2.1.3. Urgent Care Clinics
7.2.1.4. Non-practice Clinics
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Primary Care POC Diagnostics Market Outlook, by Country, Value (US$ Bn) , 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Brazil Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
7.3.1.2. Brazil Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
7.3.1.3. Mexico Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
7.3.1.4. Mexico Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
7.3.1.5. Argentina Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
7.3.1.6. Argentina Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
7.3.1.7. Rest of Latin America Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
7.3.1.8. Rest of Latin America Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Primary Care POC Diagnostics Market Outlook, 2019 - 2032
8.1. Middle East & Africa Primary Care POC Diagnostics Market Outlook, by Product Type, Value (US$ Bn) , 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Hb1Ac Testing
8.1.1.2. Glucose Testing
8.1.1.3. Autoimmune Disease
8.1.1.4. Coagulation
8.1.1.5. Fertility
8.1.1.6. Infectious Diseases
8.1.1.7. Cardiac Markers
8.1.1.8. Thyroid Stimulating Hormone
8.1.1.9. Hematology
8.1.1.10. Primary Care Systems
8.1.1.11. Decentralized Clinical Chemistry
8.1.1.12. Feces
8.1.1.13. Lipid Testing
8.1.1.14. Cancer Marker
8.1.1.15. Blood Gas/Electrolytes
8.1.1.16. Ambulatory Chemistry
8.1.1.17. Drug Abuse Testing
8.1.1.18. Urinalysis
8.2. Middle East & Africa Primary Care POC Diagnostics Market Outlook, by End User, Value (US$ Bn) , 2019 - 2032
8.2.1. Key Highlights
8.2.1.1. Pharmacy & Retail Clinics
8.2.1.2. Physician Office
8.2.1.3. Urgent Care Clinics
8.2.1.4. Non-practice Clinics
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Primary Care POC Diagnostics Market Outlook, by Country, Value (US$ Bn) , 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. GCC Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
8.3.1.2. GCC Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
8.3.1.3. South Africa Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
8.3.1.4. South Africa Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
8.3.1.5. Rest of Middle East & Africa Primary Care POC Diagnostics Market by Product Type, Value (US$ Bn) , 2019 - 2032
8.3.1.6. Rest of Middle East & Africa Primary Care POC Diagnostics Market by End User, Value (US$ Bn) , 2019 - 2032
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs by End User Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Roche Diagnostics
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. BD Biosciences
9.4.3. Danaher Corporation
9.4.4. Abbott Laboratories
9.4.5. Instrumentation Laboratory
9.4.6. bioMerieux
9.4.7. Siemens Healthcare
9.4.8. Quidel Corporation
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations